General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Where are the Opportunities in (BNTX) | news.google.com • |
Beacon Pointe Advisors LLC Purchases Shares of 52,706 BioNTech SE (NASDAQ:BNTX) | news.google.com • |
BioNTech SE ADR falls Friday, underperforms market | news.google.com • |
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports | reuters.com • |
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024 | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-06 | 2024-03 | -0.82 | -1.42 | -0.6 | -73.17% |
2024-03-20 | 2023-12 | 2.64 | 2.05 | -0.59 | -22.35% |
2024-03-20 | 2023-12 | 2.64 | N/A | N/A | N/A |
2023-11-06 | 2023-09 | -0.53 | N/A | N/A | N/A |
2023-11-06 | 2023-09 | -0.53 | 0.73 | 1.26 | 237.74% |
2023-08-07 | 2023-06 | -0.75 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-16 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-15 | HSBC | Downgrade | Buy | Hold |
2023-08-27 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-07 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-07-31 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 7.45M | 804.11M | 3.11% |
2023-06-29 | Primecap Management Company | 4.66M | 502.94M | 1.94% |
2023-06-29 | Temasek Holdings (Private) Limited | 4.52M | 487.64M | 1.88% |
2023-06-29 | Flossbach von Storch AG | 3.44M | 371.47M | 1.44% |
2023-06-29 | Artisan Partners Limited Partnership | 2.03M | 219.13M | 0.85% |
2023-06-29 | Blackrock Inc. | 1.73M | 186.84M | 0.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Horizon Fund-Capital Opportunity Fund | 2.23M | 241.18M | 0.93% |
2023-07-30 | Primecap Odyssey Aggressive Growth Fund | 1.37M | 149.11M | 0.57% |
2023-08-30 | iShares NASDAQ Biotechnology ETF | 1.37M | 165.80M | 0.57% |
2023-09-29 | New Perspective Fund Inc | 800.00K | 86.91M | 0.33% |
2023-09-29 | First Trust NYSE Arca Biotechnology Index Fund | 416.94K | 45.30M | 0.17% |
2023-06-29 | Artisan Mid-Cap Fund | 375.33K | 40.51M | 0.16% |
Dividend | Date |
---|---|
2.26067 | 2022-06-02 |
When your stock is trading 10-20x above valuation, it deserves to be punished by Wall Street. Come down a little bit more and be affordable: how about trading at value or below value.
Get out before its too late
Moderna don’t work - Biontech is falling️
$BNTX shareholders are extremely weak minded. That is the main reason why the stock is unable to rise to its true value. Market cap of $BNTX should be at least equal to, in fact significantly higher than, that of $MRNA. So the stock price should not just be higher than $MRNA, it should actually be twice. But the shareholders are too fickle-minded.
$BNTX Bears are at it again trying to play psychological games to instil fear, uncertainty and doubt through random negative comments. Wonder who are the weak-kneed investors who get affected by such crap. It’s absolutely pathetic. Stay strong investors. Don’t fall for the BS. This stock is massively undervalued. Just to catch up with the current $MRNA valuation, $BNTX should be trading at $475+. And $MRNA itself has a lot of upside. Boosters will become an annual market - UK has already signalled this and other countries will follow. The only reason why PE multiple is so low is the uncertainty about ongoing revenues, and once this uncertainly is removed the PE ratio should get closer to market average of 20+. That means the stock is worth at least $800. Stop day trading. Buy and hold. Be patient. Let the impatient transfer their wealth to you.
Please read this article from one of the biggest german news portal n-tv. the actual rating of biontech is a joke, normally the papery should be at 1.000$ or higher. Please read…we must always wait for the “tesla of biotech”!
Trotz Rekordgewinns. Börse bewertet Biontech wie Pleitekandidaten. https://www.n-tv.de/wirtschaft/Boerse-bewertet-Biontech-wie-Pleitekandidaten-article22922301.html
fuck manipulation!!!
It will be back green before close